Though more work will be needed to reveal the PI3K/AKT/GSK3β-involved accurate mechanism of action regulated by N-p-CO, the present findings clearly demonstrate that N-p-CO is exploitable as a new candidate for the prevention and treatment of diabetes. This evidence concerns the gene AKT1 and diabetes mellitus.